NCT00739999
- Conditions
- Pediatric Heterozygous Hypercholesterolemia
- Locations
-
- Pfizer Investigational Site Québec, Quebec, Canada
- Pfizer Investigational Site Athens, Greece
- Pfizer Investigational Site Oslo, Norway
Clinical trial condition
Pediatric Heterozygous Hypercholesterolemia
Explore clinical trials studying Pediatric Heterozygous Hypercholesterolemia. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies